Caxton Associates LP Johnson & Johnson Transaction History

Caxton Associates LP

$2.91 Billion
Q2 2024

A detailed history of Caxton Associates LP transactions in Johnson & Johnson stock. As of the latest transaction made, Caxton Associates LP holds 18,341 shares of JNJ stock, worth $2.87 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

18,341

Previous 18,341 -0.0%

Holding current value

$2.87 Million

Previous $2.9 Million 7.62%

% of portfolio

0.09%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $1.78 Million - $1.94 Million	12,216 Added 199.44%	18,341 $2.87 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $949,140 - $1.06 Million	-6,094 Reduced 49.87%	6,125 $953,000
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $2.58 Million - $2.78 Million	-16,729 Reduced 57.79%	12,219 $2.02 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $1.96 Million - $2.33 Million	12,945 Added 80.89%	28,948 $4.49 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $1.99 Million - $2.24 Million	12,446 Added 349.9%	16,003 $2.83 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $376,382 - $418,820	-2,333 Reduced 39.61%	3,557 $581,000
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $990,639 - $1.1 Million	5,890 New	5,890 $1.05 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $1.08 Million - $1.22 Million	-6,805 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $621,225 - $689,271	3,984 Added 141.23%	6,805 $1.16 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $6.7 Million - $7.45 Million	-41,517 Reduced 93.64%	2,821 $456,000
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $7.07 Million - $7.58 Million	44,338 New	44,338 $7.3 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $296,903 - $325,350	-2,115 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $272,433 - $328,903	2,115 New	2,115 $297,000
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $793,560 - $911,442	-6,224 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $790,136 - $884,679	6,224 New	6,224 $805,000
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $291,544 - $324,173	-2,319 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $284,865 - $342,840	2,319 New	2,319 $299,000
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $1.3 Million - $1.53 Million	-10,704 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $21,133 - $23,321	177 Added 1.68%	10,704 $1.3 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $81,315 - $96,290	-650 Reduced 5.82%	10,527 $1.35 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $758,057 - $829,692	5,777 Added 106.98%	11,177 $1.56 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $699,138 - $731,052	5,400	5,400 $702,000

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account

Caxton Associates LP Johnson & Johnson Transaction History